Hepatitis C Virus

New investigational vaccine tested for first time in humans

Published in Vaccine Weekly, December 10th, 2003

With an estimated 170 million people around the world already infected with hepatitis C, St. Louis University is testing, for the first time in humans, an investigational vaccine that researchers hope will prevent infection with the virus. The successful development of such a vaccine would represent a major step in combating this growing health problem.

St. Louis University is the only site in the country conducting this pilot study.

"There is currently no licensed vaccine to protect against the hepatitis C virus," said Sharon Frey, MD, principal investigator for the study and associate professor of internal medicine at St. Louis University School of...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (2003-12-10)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry